1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Peptide Therapeutics Market – By Type

1.3.2        Asia Pacific Peptide Therapeutics Market – By Route of Administration

1.3.3        Asia Pacific Peptide Therapeutics Market – By Synthesis Technology

1.3.4        Asia Pacific Peptide Therapeutics Market – By Application

1.3.5        Asia Pacific Peptide Therapeutics Market – By Country

2.           Peptide Therapeutics Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Peptide Therapeutics – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Asia Pacific – PEST Analysis

4.3         Expert Opinion

5.           Peptide Therapeutics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Investments on Peptide Therapeutics

5.1.2        Increasing Prevalence of Metabolic Disorders and Infectious Diseases

5.2         Market Restraints

5.2.1        Operational Limitations of Peptides

5.3         Market Opportunities

5.3.1        Strong Pipeline and Applications of Peptide Drugs

5.4         Future Trends

5.4.1        Emphasis on Automatic Peptide Synthesis

5.5         Impact Analysis

6.           Peptide Therapeutics Market – Asia Pacific Analysis

6.1         Asia Pacific Peptide Therapeutics Market Revenue Forecast and Analysis

7.           Peptide Therapeutics Market Analysis – By Type

7.1         Overview

7.2         Peptide Therapeutics Market Revenue Share, by Type (2019 and 2027)

7.3         Generic

7.3.1        Overview

7.3.2        Generic: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Innovative

7.4.1        Overview

7.4.2        Innovative: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.           Peptide Therapeutics Market Analysis – By Route of Administration

8.1         Overview

8.2         Peptide Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)

8.3         Parenteral

8.3.1        Overview

8.3.2        Parenteral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Oral

8.4.1        Overview

8.4.2        Oral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Mucosal

8.5.1        Overview

8.5.2        Mucosal: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.6         Pulmonary

8.6.1        Overview

8.6.2        Pulmonary: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.7         Others

8.7.1        Overview

8.7.2        Others: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9.           Peptide Therapeutics Market Analysis – By Synthesis Technology

9.1         Overview

9.2         Peptide Therapeutics Market Revenue Share, by Synthesis Technology (2019 and 2027)

9.3         Solid Phase Peptide Synthesis (SPPS)

9.3.1        Overview

9.3.2        Solid Phase Peptide Synthesis (SPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Liquid Phase Peptide Synthesis (LPPS)

9.4.1        Overview

9.4.2        Liquid Phase Peptide Synthesis (LPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9.5         Hybrid Technology

9.5.1        Overview

9.5.2        Hybrid Technology: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

10.        Peptide Therapeutics Market– Application

10.1      Overview

10.2      Peptide Therapeutics Market Share, Application, 2019 and 2027 (%)

10.3      Cancer

10.3.1     Overview

10.3.2     Cancer: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

10.4      Cardiovascular Disorders

10.4.1     Overview

10.4.2     Cardiovascular Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

10.5      Metabolic Disorder

10.5.1     Overview

10.5.2     Metabolic Disorder: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

10.6      Respiratory Disorders

10.6.1     Overview

10.6.2     Respiratory Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

10.7      Pain

10.7.1     Overview

10.7.2     Pain: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

10.8      Dermatology

10.8.1     Overview

10.8.2     Dermatology: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

11.        Peptide Therapeutics Market – Asia Pacific Analysis

11.1      Asia Pacific: Peptide Therapeutics Market

11.1.1     Overview

11.1.2     Asia Pacific: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)

11.1.3     Asia Pacific: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

11.1.4     Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.5     Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

11.1.6     Asia Pacific: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

11.1.7     Asia Pacific: Peptide Therapeutics Market, by Country, 2019& 2027 (%)

11.1.8     China: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1       China: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2       China: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

11.1.8.3       China: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.8.4       China: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

11.1.8.5       China: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

11.1.9     Japan: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1       Japan: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2       Japan: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

11.1.9.3       Japan: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.9.4       Japan: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

11.1.9.5       Japan: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

11.1.10  India: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1    India: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2    India: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

11.1.10.3    India: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.10.4    India: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

11.1.10.5    India: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

11.1.11  South Korea: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.11.1    South Korea: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.11.2    South Korea: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

11.1.11.3    South Korea: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.11.4    South Korea: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

11.1.11.5    South Korea: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

11.1.12  Australia: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.12.1    Australia: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.12.2    Australia: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

11.1.12.3    Australia: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.12.4    Australia: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

11.1.12.5    Australia: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

11.1.13  Rest of Asia Pacific: Peptide Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.13.1    Rest of Asia Pacific: Peptide Therapeutics Market- Revenue and Forecasts to 2027 (USD Million)

11.1.13.2    Rest of Asia Pacific: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

11.1.13.3    Rest of Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.13.4    Rest of Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

11.1.13.5    Rest of Asia Pacific: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

12.        Impact of COVID-19 Pandemic on Asia Pacific Peptide Therapeutics Market

12.1      Asia-Pacific: Impact Assessment of COVID-19 Pandemic

13.        Company Profiles

13.1      Amgen Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      EVER Pharma GmbH

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Polypeptide Group

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      TEVA PHARMACEUTICAL INDUSTRIES LTD

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      AstraZeneca

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Bristol-Myers Squibb Company

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      GlaxoSmithKline plc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Novo Nordisk A/S

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Sanofi

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Asia Pacific Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 2.             Asia Pacific Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 3.             Asia Pacific Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

Table 4.             Asia Pacific Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.             China Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             China Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 7.             China Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

Table 8.             China Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.             Japan Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 10.          Japan Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 11.          Japan Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

Table 12.          Japan Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 13.          India Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          India Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 15.          India Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

Table 16.          India Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 17.          South Korea Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 18.          South Korea Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 19.          South Korea Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

Table 20.          South Korea Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 21.          Australia Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 22.          Australia Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 23.          Australia Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

Table 24.          Australia Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 25.          Rest of Asia Pacific Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 26.          Rest of Asia Pacific Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 27.          Rest of Asia Pacific Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

Table 28.          Rest of Asia Pacific Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 29.          Glossary of Terms, Peptide Therapeutics Market

LIST OF FIGURES

Figure 1.           Peptide Therapeutics Market Segmentation

Figure 2.           Peptide Therapeutics Market Segmentation, By Country

Figure 3.           Asia Pacific Peptide Therapeutics Market Overview

Figure 4.           Innovative Segment Held Largest Share of Peptide Therapeutics Market

Figure 5.           Asia Pacific Peptide Therapeutics Market – Leading Country Markets (US$ Million)

Figure 6.           Asia Pacific PEST Analysis

Figure 7.           Peptide Therapeutics Market Impact Analysis of Drivers and Restraints

Figure 8.           Asia Pacific Peptide Therapeutics Market – Revenue Forecast and Analysis – 2019- 2027

Figure 9.           Peptide Therapeutics Market Revenue Share, by Type (2019 and 2027)

Figure 10.        Generic: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Innovative: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Peptide Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)

Figure 13.        Parenteral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Oral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Mucosal: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Pulmonary: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Others: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Peptide Therapeutics Market Revenue Share, by Synthesis Technology (2019 and 2027)

Figure 19.        Solid Phase Peptide Synthesis (SPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Liquid Phase Peptide Synthesis (LPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Hybrid Technology: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Peptide Therapeutics Market Share, Application, 2019 and 2027 (%)

Figure 23.        Cancer: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 24.        Cardiovascular Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 25.        Metabolic Disorder: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 26.        Respiratory Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 27.        Pain: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 28.        Dermatology: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 29.        Asia Pacific: Peptide Therapeutics Market, by Key Country – Revenue (2019) (USD Million)

Figure 30.        Asia Pacific Peptide Therapeutics Market Revenue and Forecast to 2027 (USD Million)

Figure 31.        China: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.        Japan: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 33.        India: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.        South Korea: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        Australia: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 36.        Rest of Asia Pacific: Peptide Therapeutics Market- Revenue and Forecasts To 2027 (USD Million)

Figure 37.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets